Haemonetics (HAE) Misses Q4 EPS by 5c; Guides FY16 EPS
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $73.22 +0.95%
EPS Growth %: -0.9%
Financial Fact:
Operating income: 24.79M
Today's EPS Names:
MAYS, CRMT, REPL, More
EPS Growth %: -0.9%
Financial Fact:
Operating income: 24.79M
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q4 EPS of $0.47, $0.05 worse than the analyst estimate of $0.52. Revenue for the quarter came in at $226.5 million versus the consensus estimate of $239.2 million.
Haemonetics sees FY2015 EPS of $1.98-$2.08, versus the consensus of $2.09.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
- William Blair Upgrades Backblaze Inc (BLZE) to Market Perform
- UBS Reiterates Buy Rating on General Motors (GM) as Defense Opportunity in Focus
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
